PLAQUE FORMATION AND BIOCHMICAL MARKERS OF ISCHEMIA - PowerPoint PPT Presentation

1 / 23
About This Presentation
Title:

PLAQUE FORMATION AND BIOCHMICAL MARKERS OF ISCHEMIA

Description:

Dr Azra Parveen Senior Registrar Medicine Acute myocardial infarction is the rapid development of myocardial necrosis caused by a critical imbalance between the ... – PowerPoint PPT presentation

Number of Views:117
Avg rating:3.0/5.0
Slides: 24
Provided by: abaa
Category:

less

Transcript and Presenter's Notes

Title: PLAQUE FORMATION AND BIOCHMICAL MARKERS OF ISCHEMIA


1
PLAQUE FORMATION AND BIOCHMICAL MARKERS OF
ISCHEMIA
  • Dr Azra Parveen
  • Senior Registrar
  • Medicine

2
Acute Myocardial Infarction
  • Acute myocardial infarction is the rapid
    development of myocardial necrosis caused by a
    critical imbalance between the oxygen supply
  • and demand of the myocardium.
  • It is an irreversible myocardial injury from
    prolonged ischemia.
  • Accurate and early diagnosis is important in
    minimizing cellular damage and, consequently, in
    obtaining a successful outcome for the patient

3
(No Transcript)
4
Plaque formation
  • Risk Factors
  • Hyperlipiemia-LDL
  • Diabetes
  • Hypertension
  • Smoking
  • Obesity

5
  • Initiation of atherosclerosis
  • Expression of adhesion molecules that allows the
    leukocytes to stick to the arterial wall.
  • Early lesion- Fatty streak
  • Upon entry into the arterial wall blood
    monocytes begin to scavenge lipids and become
    foam cells.

6
  • Stable atherosclerotic plaque
  • Foam cells release further cytokines and
    effector molecules that stimulate smooth muscle
    cell migration from the arterial intima into the
    media, as well as smooth cell proliferation.
    Smooth muscle cells together with lipd core and
    matrix form a stable atherosclerotic plaque that
    will remain asymptomatic until it becomes large
    enough to obstruct arterial flow.

7
  • Vulnerable plaque
  • Inflammatory cell infiltrate, smooth muscle cell
    death through apoptosis and matrix degradation by
    matrix metalloproteinases generate a plaque with
    a thin fibrous cap and lipid-rich necrotic core.
    It is called a vulnerable plaque and it can
    rupture. Plaque rupture will expose its contents
    to blood and trigger platelet aggregation and
    thrombosis. It will result in partial or complete
    obstruction of the blood vessel leading to
    ischemia or infarction

8
(No Transcript)
9
(No Transcript)
10
Cardiac Markers
  • Markers of cardiac myocyte necrosis
  • Myoglobin
  • CK
  • Ck-MB
  • Troponin I T

11
(No Transcript)
12
Myoglobin
  • Myoglobin is an iron and oxygen binding protein
    found in muscle tissue
  • It is only found in the blood stream when it is
    released following muscle injury
  • It is a sensitive marker for mucle injury making
    it a potential marker for myocardial infarction
  • However elevated myoglobin has low specificity
    for the diagnosis of myocardial infarction and
    therefore is not the preferred test

13
Creatine kinase
  • Cytoplasmic CK is a dimer, composed of M and/or B
    subunits, which associate forming CK-MM, CK-MB
    and CK-BB isoenzymes.
  • CK-MM is the main isoenzyme found in striated
    muscle
  • CK-MB is found mainly in cardiac muscle
  • CK-BB is the predominant isoenzyme found in brain

14
  • Serum total CK activity and CK-MB concentration
    rise in parallel following myocardial injury,
    starting to increase 4 6 h after injury,
    reaching peak serum concentrations after 1224 h
    and returning to baseline after 4872 h. Serum
    CK-MB is considerably more specific for
    myocardial damage than is serum total CK, which
    may be elevated in many conditions where skeletal
    muscle is damaged.
  • Consequently, CK should not be used for the
    diagnosis of myocardial injury unless used in
    combination with other more specific cardiac
    markers.

15
Total CK can be elevated
  • IM injection
  • Traumatic damage to skeletal muscle
  • Hypothermia
  • Exercise
  • Intoxication
  • Dose-related side effect in statin treatment

16
CK-MB FRACTION
  • CK-MB fraction CKMB /total CK
  • Rationale for using CK-MB fraction
  • CK-MB fraction greater than 2.5 is suggestive of
    myocardial injury

17
Troponins
  • Troponin is a regulatory complex of 3 protein
    subunits located on the thin filament of the
    myocardial contractile apparatus. Its function is
    the regulation of striated and cardiac muscle
    contraction. The complex regulates the
    calcium-modulated interaction between actin and
    myosin on the thin filament.
  • Troponin C (18 kd)
  • Calcium-binding subunit
  • No cardiac specificity
  • Troponin I (26.5 kd)
  • Actomyosin-ATP-inhibiting
  • subunit
  • Cardiac-specific form
  • Troponin T (39 kd)
  • Anchors troponin complex
  • to theTropomyosin strand

18
(No Transcript)
19
  • In the absence of calcium ions, tropomyosin
    blocks access to the mysosin binding site of
    actin. When calcium binds to troponin, the
    positions of troponin and tropomyosin are altered
    on the thin filament and myosin then has access
    to its binding site on actin..
  • When the calcium level decreases, troponin locks
    tropomyosin in the blocking position and the thin
    filament slides back to the resting state.

20
Tissue Specificity of TroponinSubunits
  • Troponin C is the same in all muscle tissues
  • Troponins I and T have cardiac-specific forms,
    cTnI and cTnT
  • cTnI and cTnT remain elevated for 10 to 14 days

21
Troponin Release Kinetics
  • Detectable in blood 4-12 h, similar to CKMB
  • Peaks 12-38 h
  • Remains elevated for 10-14 days

22
(No Transcript)
23
(No Transcript)
Write a Comment
User Comments (0)
About PowerShow.com